Genematrix is a company that develops molecular diagnostic products. Its core platform technologies (C-TAG, Omniplex, EnCleap, TriO, and REMP) focus on various diseases, such as hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and more. In addition to detection kits, the company develops vaccines as well as natural pharmaceutical materials for health improvement or treatment.